Hypercalcemia
Treatment Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016
Future Market Insights
www.futuremarketinsights.com
[email protected]
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Sector Coverage








Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Report
Description
Report Description
Hypercalcemia is a medical condition which involves elevation of calcium level in the
blood. Surplus calcium levels in your blood can create kidney stones, obstruct the way
your heart and brain functions and weaken your bones. Hypercalcemia is commonly
result of hyperactive parathyroid glands. Hypercalcemia is generally accompanied by
several symptoms like feeling sick, tiredness, vomiting, bone pains and kidney stones.
Hypercalcemia is the most common metabolic disorder related with neoplastic diseases.
It has estimated that hypercalcemia occurs in about 10% to 20% of all patients with
cancer. Hypercalcemia is caused due to excessive release of calcium in the skeletal system
and due to increased intestinal calcium absorption in the body. Hypercalcemia treatment
focuses on lowering the serum calcium concentration in the body. Some of the non pharmacological therapies used in the treatment of hypercalcemia are as mobilization,
saline diuresis and volume expansion, Inhibition of bone resorption, reduction of
gastrointestinal calcium absorption and dialysis.
Hypercalcemia Treatment Market: Drivers and Restraints
Presently, the global hypercalcemia treatment market is an attractive market, and is
primarily driven by the high adoption rate of novel therapies. Moreover, factor such as
increased government support for developing effective medications for rare disease such
as hypercalcemia is expected to drive the growth of this market. However, factors such as
high cost of therapy and stringent drug regulatory policies might impede the growth of
the market.
Report
Description
Report Description
Request free sample Report: http://www.futuremarketinsights.com/reports/sample/repgb-1320
Hypercalcemia Treatment Market: Segmentation
Hypercalcemia Treatment market is classified on the basis of drug type, indication, end
user and geography.
Based on the drug therapies type, the global hypercalcemia Treatment market is
segmented into the following:
• Bisphosphonates
• Antidote or Hypercalcemia Agents
• Calcimimetic Agent
• Glucocorticoids
• Antineoplastic drugs
• Minerals
Based on the indications, the global hypercalcemia Treatment market is segmented into
the following:
• Primary Hyperparathyroidism
Report
Description
Report Description
• Antidote or Hypercalcemia Agents
• Calcimimetic Agent
• Glucocorticoids
• Antineoplastic drugs
• Minerals
Based on the indications, the global hypercalcemia Treatment market is segmented into
the following:
• Primary Hyperparathyroidism
• Secondary Hyperparathyroidism
• Tertiary Hyperparathyroidism
• Humoral Hypercalcemia of Malignancy
• Other (Thyrotoxicosis, Immobilization etc.)
Based on the type end user, the global hypercalcemia Treatment market is segmented
into the following:
• Hospitals Clinics
Report
Description
Report Description
• Private Clinics
• Retail Pharmacies and Drug Stores
• e-commerce
Hypercalcemia Treatment Market: Overview
The primary hyperparathyroidism and humoral hypercalcemia of malignancy type is
expected to dominate the global hypercalcemia market over the forecast period as they
account for 90% of the hypercalcemia cases. Growing incidence of hypercalcemia,
increasing awareness among the people and developments in new advance treatment
are some other factors which are expected to support the growth of global
hyperparathyroidism market over the forecast period.
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1320
Hypercalcemia Treatment Market: Region-wise Outlook
Depending on geographic regions, global hypercalcemia market is segmented into seven
key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific
Excluding Japan, Japan and Middle East & Africa. In terms of geography, North America is
the leading market owing to the high incidence rate of hypercalcemia in the U.S. various
research studies suggests that the incidence of hypercalcemia in the U.S. is almost 1 to 2
cases per 1000 adults.
Report
Description
Report Description
However, other regions such as Latin America, MEA and APAC are estimated to witness
sluggish growth due to the high costs of these therapies and low awareness among
population.
Hypercalcemia Treatment Market: Key Players
The companies involved in the development and commercialization of hypercalcemia
treatment products are Cipla Inc., Sun Pharmaceutical Industries Ltd., Amgen Inc., Genta
Inc., Par Pharmaceutical Companies, Inc., Novartis International AG Pfizer Inc. and others.
Browse full report: http://www.futuremarketinsights.com/reports/hypercalcemiatreatment-market
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705